Report Code: A03212 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Metabolic disorders usually occur due to disruption of the normal processes of the body. These disorders can be hereditary or acquired and the symptoms differ from person to person. Some metabolic disorders cause mild symptoms that can be managed with slight medication and lifestyle changes, whereas few can cause life-threatening symptoms, such as breathing problems, seizure, and organ failure. The treatment for inherited metabolic disorders requires long-term nutritional supplementation and treatment, while those that are caused due to some other disease are treated after those conditions are cured.
The introduction of patient assistance programs to provide treatment for a range of metabolic disorders and the rise in awareness about the availability of therapeutics for these diseases drive the market growth. Moreover, the advancement in technology and increase in funding for the development of novel therapeutic approaches from government and non-government organizations are expected to further boost the market. Some of the commonly available treatment procedures for metabolic disorders include a range of therapeutic medications such as vitamin, mineral, physical therapy, and surgeries.
The global metabolic disorders therapeutics market is segmented based on product, disease, and region. Based on product, it is categorized into metachromatic leukodystrophy, globoid leukodystrophy, hepatic encephalopathy, and others. Based on application, it is divided into diabetes, obesity, hypercholesterolemia, and lysosomal storage diseases. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major players, such as AbbVie, Novo Nordisk, Actelion Pharmaceuticals, Sanofi, Biocon, Merck, Boehringer Ingelheim, AstraZeneca, CymaBay Therapeutics, and Eli Lilly and Company, are also provided in this report.
Key Benefits
Metabolic Disorders Therapeutics Market Report Highlights
Aspects | Details |
---|---|
By Product |
|
By Disease |
|
By Region |
|
Key Market Players | Biocon, Eli Lilly and Company, AstraZeneca, Merck, Actelion Pharmaceuticals, CymaBay Therapeutics, AbbVie, Boehringer Ingelheim, Novo Nordisk, Sanofi |
Loading Table Of Content...
Start reading.
This Report and over 71,223+ more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
15%
Discount
15%
Discount
Enterprise
License/PDF
20%
Discount
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers